chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6:00 pm sore red in shot area. 10:00 pm very sore, hot, some swelling. 12/23/2015 7:00 am painful, hot redness spreading, felt ill, head, body ache, tired slight temp, chills. 12:00 pm upper two thirds of arm red hot swollen & slight rash. 12/24/2015 feeling better but arm still sore and redness wraps around arm and shoulder.
A lot of pain in arm; GI issues/some GI upset; Diarrhea; Nausea; Woke up in the middle of my sleep; I have now like 101 fever; Chills; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 24Dec2020 at single dose for COVID-19 immunization. Medical history included dehydration and COVID-19 in the end of November. The patient did have COVID-19 in Nov2020, it was a pretty bad case where the patient was in the hospital for like 6 days, not ventilated but the patient was on all those medications (unspecified medications), the patient had it pretty bad. The patient had pneumonia in both lungs and dehydration, the patient thought. The patient's concomitant medications were not reported. The patient got the vaccine on 24Dec2020 and the patient's symptoms that the patient was having with the COVID in the end of Nov2020, the patient hadn't have anything, any issues with COVID since then. The patient got the vaccine at the hospital on 24Dec2020 and overnight, the patient was having, like initially, right after the vaccine, the patient had a lot of pain in arm. And then the patient started getting GI issues with diarrhea and things like that which the patient did have when the patient had COVID, a month ago and nausea and starting like last night, overnight, the patient woke up in the middle of sleep, the patient started getting like fever. The patient was now like 101 fever, when the patient had COVID, it was like 103. So it was not as bad as when the patient had COVID, it was like 101 fever, it was like chills, and some GI upset. The outcome of events are unknown  Information on the lot/ batch number has been requested.
Suspect Covid breakthrough- came through ED and now admitted per caller, 7/27/2021 Vaccine #2 from Pfizer, 03/03/2021, caller did not have injection site Patient came into ED for Covid swab and symptoms on 7/25/2021 and then admitted Patient is hospitalized still
18JUN96 gen hives-gave DPh;20JUN96 seen by office-referred to allergist
Skin rash with some itching appeared on hands, arms, and legs (about 25-30 raised bumps).  Noticed this two days after Flu shot.
5 days after getting the second dose I had some issues with headaches, I took Tylenol for that, then my ears were clogged and developed a painful growth behind my ear like a nodule. Also, my face swelled up and that lasted for about a week and a half. 30 minutes after getting the dose my breasts change color to pink and they were swollen and tender. Both underneath my armpits are very tender. My feet swelled up the same night. They are still swollen on and off. After taking both doses I noticed that there was an increase of floaters but that lasted only the first day. Moderate headaches on and off. My face was sore. I went to urgent care to take care of the nodule behind my ear. I had problems hearing with that right ear. They had trouble seeing anything on the outside so they said that it must be something on the inside. They told me to take Ibuprofen sodium for the nodule behind the ear.
This spontaneous report as received from nurse practitioner refers to a patient of unknown age and gender. On 07-DEC-2005 patient was vaccinated with VAQTA first dose (dose unit, lot number and expiry date route unknown). On 12-JUl-2006, patient was vaccinated with second dose of VAQTA, third dose on 15-NOV-2012, fourth dose on 20-MAY-2013. No adverse effect reported. The outcome of events was unknown. Additional information has been requested.
MUSCULAR PAIN; MILD BRAIN FOG; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. .The batch number was not reported. Per procedure no follow up will be requested for this case. No concomitant medications were reported. On 26-MAR-2021, the subject experienced mild brain fog. On 27-MAR-2021, the subject experienced muscular pain. The action taken with covid-19 vaccine was not applicable. The outcome of the mild brain fog and muscular pain was not reported. This report was non-serious.
Red, swollen right upper arm treated with antibiotics on 08/04/2006 by congential heart disease provider for cellulitis.
On saturday 5/25/19 patient contacted the pharmacy that her arm was swollen where she received the shot and was very painful. She had a temp of 102. Pharmacist recommended she go to the ER. Patient upon going to hospital her oxygen levels were low. They admitted her and she stayed in the hospital for 4 days on iv antibiotics.
Within 24 hrs after rcving the flu nasal inhalant the ARGAS (sinus ARGAS) on my face had the feeling of a mild sunburn and lasted for about a week.
flu; Initial information was received on 12-Oct-2020 regarding an unsolicited valid non-serious social media.   This case is linked to case 2020SA289370 (same reporter).  This case involved an unknown demographic patient who experienced flu (influenza), after receiving INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s), family history and concomitant medication were not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, the patient developed non-serious flu (influenza), (unknown latency) following the administration of INFLUENZA VACCINE.  The patient did not receive another flu vaccine.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  On an unknown date, the patient had recovered from the event after 3 weeks.  There will be no information available on the batch number for this case.
This spontaneous report was received from a physician and refers to a patient of unknown age (also reported as "0") and gender. No information about the patient's pertinent medical history, concomitant medications and concurrent conditions was provided. On 27-APR-2017, the patient was vaccinated with an improperly stored dose of ROTATEQ oral solution, lot # M041181 (dose, and expiry date were not specified) for prophylaxis. The administered dose of ROTATEQ underwent a temperature excursion of 48 Fahrenheit degrees for 30 minutes. There was no Digital Data Logger involved. No previous temperature excursion was reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information is not expected as all available information has been received. Sender's Comments: US-009507513-1704USA001661:
Large red swelling in left arm, itching over left arm. Cellulitis diagnosed on 3rd day after shot.
This is a 55 year old female who presents with a history of right shoulder, upper arm and upper back pain (mainly centering on the upper right scapula) that started on Saturday, Jan 16th.  States that onset was sudden and limited her range of motion; when she turns her neck towards the left, the pain is exacerbated.  She denies arm or hand weakness or sensory dysfunction (i.e. no tingling or numbness of the fingers).  She does not note any fever or erythema of the shoulder.  She has been treating with ibuprofen, which she states she has seen improvement of the pain.  Two weeks ago, she received a COVID-19 vaccine in the right arm, although from the picture she took the vaccine appeared to be administered higher than the deltoid.  Suspect this could represents shoulder injury related to vaccine injury.  Other than synthroid she takes no other medications on a routine basis.  She stated that she developed an iatrogenic hepatitis after taking either rifampin or INH, and was told not to take those medications; however, she reports no history of anaphylaxis to a drug or vaccine.
Warm flush in neck and head a few minutes after injection. Six hours after injection, headache with mild fever, chills and join aches. Nine days after start of symptoms, severe headache with neck pain. Was prescribed antibiotics for sinus infection symptoms and given a chest X-ray. On March 26th was instructed to go to ER by primary but I refused at the time.  On 12th day after vaccination vision in left eye became blurry with swelling. Also had numbness in lower back radiating to the front. On 16th day, 03/29/2021, primary care physician again instructed me to go to ER. I was admitted to the hospital. Released 03/31/2021. Was treated for head and neck pain and given several tests.
Pt held in room for 10 mins after imm's for routine waiting period after imm's.  Felt fine and was released.  Pt did well until 15 min after receiving imm's.  Pt was out in waiting room with mother.  She felt light headed and dizzy then fainted.  Reportedly fell forward and hit front of head on counter then fell back and hit occiput on tile floor.  LOC for approx 10 sec.  No sz activity.  Immediately awake and talking.  Does not remember fall but remembers events immediately prior and after.  GCS 15.  Pupils equal and reactive.  no vomiting.  Vital taken and able to stand and walk with help to exam room after 5 minutes.  Occiput noted boggy with 1 cm lac.  No crepitis noted.  Pressure dressing applied.  Able to take sips of water and ate orange slices.  Neuro intact.  Mild occipital headache.  Two ASA Free Exedrine given for headache.  Pt talking, VSS, memory intact except for the fall.  GCS 15.  Sent to ER via parent's vehicle at 5:10.  Mother says now that pt has not eaten today.
Patient reported sharp pain at time of injection. Patient's husband came in 24 hours later to pharmacy to report that patient had difficulty moving arm, some numbness, and was experiencing significant pain all day. Patient went to hospital and was examined by physician. Patient's husband states that physician's opinion was that vaccine liquid and/or needle struck nerve and is causing the pain.
Patient was scheduled by appointment for a pediatric pfizer. The age limit for pediatric pfizer is 11  and patient had turned 12 years old the day before scheduled appointment (1-13-22). I verified date of birth was correct but did not realize the patient had turned 12 at the time of administration. After vaccine was administered and the waiting time after the vaccine the patient left without any issues. After verifying the vaccine paperwork at the end of the day, the error was found.
Information has been received from a registered nurse concerning an 8 year old female who was vaccinated on 07/02/1996 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen in December 2003 with spots on her trunk and face.  The child was noted to have chickenpox breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
This report was received from Glaxo Smith Kline and was assigned manufacturer report number 269534. This was originally reported by a consumer. This spontaneous report refers to a male patient of an unknown age concerning himself. The patient's pertinent medical history, drug reactions, allergies and concomitant therapies were not reported. On an unknown date, the patient had received ZOSTAVAX(dosage scheduled, route of administration, lot # and expiration date were not provided) for prophylaxis. It was stated that "my shingles is still recurring" on an unspecified date. There was no product quality complaint (PQC) involved. At the time of reporting, the outcome of the event was unknown. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
8 days after immunizations, fever up to 104, seizure, hemetemesis, very irritable, lethargic. At 9 days rash, macular, blotchy started on face and moved down.  All symptoms resolved by 11 days.
Severe joint pain starting about 6 months after the last vaccination that has become progressively worse. I tried anti-inflammatory medication to east the pain but they didn't help.
No signs of symptoms have been reported; Improper storage of product in use; This spontaneous report was received from a registered nurse concerning a 9-month-old male patient.      The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 27-JUL-2021, a temperature excursion occurred due to power outage. Temperature excursion was reported as follows: temperature -0.5 Celcius degrees (C) (1 hour 30 minutes) and 13.6 C (1 hour 40 minutes); time frame 2 hours 10 minutes (cumulative). There was no other previous temperature excursion. It was reported that there was miscommunication when reporting high/low reading of temperature, and initially, the site received clearance to use vaccines on 28-JUL-2021. On 29-JUL-2021, the patient was vaccinated with the third dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscularly in the left thigh (lot # T033149, expiration date 19-NOV-2022) for prophylaxis (product storage error). On that date, temperature readings were corrected which changed outcome, but the vaccine had already been administered. No signs or symptoms were reported. combinationproductreport: Yes; brandname: RECOMBIVAX HB SYRINGE (DEVICE); commondevicename: Hepatitis B Vaccine (Recombinant); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T033149; expirationdate: 19-NOV-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability; Sender's Comments:  US-009507513-2107USA008884:
Seizure activity in absence of known  seizure disorder while eating breakfast.  Seizure lasted about 2.5 minutes.  Post-ictal period about 40 minutes.
This spontaneous report has been received from a pharmacist, referring to a female patient under 65 years old. The pharmacist stated that the patient did not have any chronic medical condition. Information about her pertinent medical history, previous drug reactions, allergies and concomitant medication was not provided. On an unknown date, the patient was vaccinated with the first dose of PNEUMOVAX 23 injection for prophylaxis (frequency, route and anatomical location of vaccination, lot number and expiration date were not provided). The pharmacist reported that the clinic where the patient worked, suggested her to receive the vaccine since she worked with the elderly; therefore, the patient was coming back for a second dose.
Intermittent racing/pounding heart - started about 2 weeks after shot; Back pain started about 2 weeks after shot; Grip and hand weakness in grasping items started about 2 week after shot; Headaches - started on Day 1 and comes and goes; Extreme tiredness that comes and goes - started on Day 1; Joint pain - started on day 1 and stopped about day 3; Tingling and numbness started 3 days after first shot and occurs various places in the body; Tingling and numbness started 3 days after first shot and occurs various places in the body; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 26Mar2021 at 09:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus (lupus syndrome), hypothyroid, alopecia, atopic dermatitis, rosacea, penicillin allergy, egg allergy and dairy allergy (milk allergy). Concomitant medications included levothyroxine sodium (SYNTHYROID), cetirizine hydrochloride (ZYRTEC) and vitamin d nos (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received aspirin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, on day1 the patient experienced headaches which were coming and going, extreme tiredness which were coming and going and joint pain which stopped about day3. On an unknown date in Mar2021,3 days after the first shot, the patient had tingling and numbness occurring in various places in the body. On an unknown date in Apr2021, 2 weeks after the vaccination, the patient experienced Intermittent racing/pounding heart, back pain, grip and hand weakness in grasping items. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of joint pain was recovered on an unknown date in Mar2021 after the duration of 3 days; while that of the events headache, extreme tiredness, tingling and numbness occurring in various places in the body, intermittent racing/pounding heart, back pain, grip and hand weakness were unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Resident is at risk  for adverse reaction/event status post vaccine administration error. Licensed nurse inadvertently administered Moderna vaccine twice before the 28th day. Resident is being monitored every hour and will notify MD if noted. At this time  Resident is in stable condition.
Information has been received from a registered pharmacist concerning a 40 year old female patient who on 23-JAN-2009 was vaccinated with ZOSTAVAX (Merck) (lot # 663673/1710X) learned she was pregnant. It was not known how pregnancy was confirmed (urine, ultrasound, blood). Also no details about gestation such as last menstrual period (LMP) or due date known. The patient had contacted her OB/GYN for medical attention. Follow up information has been received from the registered pharmacist that the patient reported on Christmas Eve 2008 she had had intercourse and became pregnant. The patient received the vaccination on 23-JAN-2009, not knowing she was pregnant, and then her pregnancy was confirmed by her physician on 28-JAN-2009. On 09-SEP-2009 the patient reported that she had carried the pregnancy to term, and had a healthy baby boy who was born with a cleft lip (NOS). According to the patient's physician, the cleft lip was unrelated to the shingles vaccination she had gotten in pregnancy. No further information is available.
After receiving my third shot (booster) I had the usual soreness in the shoulder area and felt a little off. Twelve days later (12/23/21) while weight training I got up and had extreme dizziness. I never had any symptoms like this. I went to see my doctor on 01/03/22 while still having symptoms to a lesser extent. Was checked over and did blood work that came back normal. We scheduled a stress test EKG everything was normal. The Doctor thought my symptoms were possibly vertigo or an inner ear issue . I had the symptoms come back, to a much lesser degree, in February and again in March.
I'm just tired; I'm very tired; my arm is sore; the post nasal drip, kind of  like chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administration date 06May2021 (Lot number: EW0167) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing), notes: Verbatim: High Blood pressure; "Diabetes mellitus" (unspecified if ongoing), notes: Verbatim: Diabetes. Concomitant medication(s) included: BENICAR taken for hypertension; METFORMIN taken for diabetes mellitus; BABY ASPIRIN. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "I'm just tired; I'm very tired"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "my arm is sore"; CHILLS (non-serious), outcome "unknown", described as "the post nasal drip, kind of  like chills". Therapeutic measures were taken as a result of pain in extremity.  Additional information: Consumer stated, Well, I am calling about possible side effects. I took the vaccine yesterday afternoon so, I have the, they gave me a sheet with the possible side effects but I just want to call, the follow up because it didn't say whether it's like any severe reaction or severe side effect. I'm just tired, is that common? Because it's the first vaccine shot, I'm very tired. Of course, my arm is sore and I thought I'll get a cold, you know, the post nasal drip, kind of  like chills, not a fever, I don't have a fever but I do feel like I have chills. Consumer stated, I just took a Tylenol, just because my arm is sore, just a Tylenol. Consumer stated, 500 for 2, (500mg). Dose of Metformin: Consumer stated, 1000 for 2 tablets. (further clarification unknown).  No follow-up attempts are needed. No further information is expected.
Panic attack type symptoms, closing vision, appears due to high blood pressure never before an issue, now chronic